Market Research Logo

MannKind Corporation (MNKD) - Financial and Strategic SWOT Analysis Review

MannKind Corporation (MNKD) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

MannKind Corporation (MannKind) is a bio-pharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products to treat diseases such as diabetes and cancer. The company’s product portfolio comprises one marketed product Afrezza, a rapid-acting inhaled insulin aimed to enhance glycemic control and is indicated for the treatment of diabetes. Afrezza is the only approved inhaled insulin for the treatment of diabetes in the US. The company develops its products based on its proprietary formulation technology, Technosphere.

MannKind Corporation Key Recent Developments

Dec 23,2015 MannKind Announces Appointment of Duane DeSisto as Chief Executive Officer
Nov 20,2015 MannKind Announces Senior Management Changes
Oct 23,2015 MannKind Announces Dual Listing on the Tel Aviv Stock Exchange
Aug 10,2015 Mannkind Announces Addition of Chief Medical Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
MannKind Corporation - Key Facts
MannKind Corporation - Key Employees
MannKind Corporation - Key Employee Biographies
MannKind Corporation - Major Products and Services
MannKind Corporation - Medical Equipment Pipeline Products Data
MannKind Corporation Pipeline Products by Equipment Type
MannKind Corporation - History
MannKind Corporation - Company Statement
MannKind Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
MannKind Corporation - Business Description
MannKind Corporation - Corporate Strategy
MannKind Corporation - SWOT Analysis
SWOT Analysis - Overview
MannKind Corporation - Strengths
Strength - First-in-Class Product - Afrezza
Strength - Focused Research and Development
Strength - Technosphere Technology Platform
MannKind Corporation - Weaknesses
Weakness - History of Operating Losses
Weakness - Termination of Sanofi License Agreement
MannKind Corporation - Opportunities
Opportunity - Increased Aged Population
Opportunity - Diabetes Market Potential
Opportunity - Business Initiatives
MannKind Corporation - Threats
Threat - Competitive Pressures
Threat - Government Regulations
Threat - Rapid Changes in Technology
MannKind Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
MannKind Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
MannKind Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
MannKind Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 23, 2015: MannKind Announces Appointment of Duane DeSisto as Chief Executive Officer
Nov 20, 2015: MannKind Announces Senior Management Changes
Oct 23, 2015: MannKind Announces Dual Listing on the Tel Aviv Stock Exchange
Aug 10, 2015: MannKind Reports 2015 Second Quarter Financial Results
Aug 10, 2015: Mannkind Announces Addition of Chief Medical Officer
May 21, 2015: James S. Shannon Rejoins MannKind's Board of Directors
May 07, 2015: MannKind Reports 2015 First Quarter Financial Results
Feb 24, 2015: MannKind Reports 2014 Fourth Quarter and Full Year Financial Results
Jan 12, 2015: MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
MannKind Corporation, Key Facts
MannKind Corporation, Key Employees
MannKind Corporation, Key Employee Biographies
MannKind Corporation, Major Products and Services
MannKind Corporation Number of Pipeline Products by Equipment Type
MannKind Corporation Pipeline Products by Equipment Type
MannKind Corporation, History
MannKind Corporation, Other Locations
MannKind Corporation, Key Competitors
MannKind Corporation, Ratios based on current share price
MannKind Corporation, Annual Ratios
MannKind Corporation, Interim Ratios
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
MannKind Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
MannKind Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
MannKind Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
MannKind Corporation Pipeline Products by Equipment Type
MannKind Corporation, Performance Chart (2011 - 2015)
MannKind Corporation, Ratio Charts
MannKind Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
MannKind Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
MannKind Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
MannKind Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report